Cogent Biosciences Inc (COGT) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $39.46
• Market Cap: $6.49B
• EPS: $-2.16
• 52-Week High: $43.73
• 52-Week Low: $3.72

Market Sentiment

Cogent Biosciences Inc currently has a Bearish sentiment score of -0.18.

About Cogent Biosciences Inc

Cogent Biosciences, Inc. is an innovative biotechnology company located in Cambridge, Massachusetts, focused on developing precision therapies for genetically defined diseases. Utilizing its proprietary platform, Cogent aims to deliver targeted therapeutic solutions that address specific genetic mutations, significantly improving patient outcomes. With a robust pipeline and an emphasis on transformative treatments, the company is poised to become a key player in the precision medicine sector,...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Cogent Biosciences Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does COGT pay dividends?

Cogent Biosciences Inc (COGT) does not currently pay a regular dividend.

What is COGT's market cap?

Cogent Biosciences Inc (COGT) has a market capitalization of $6.49B with a current stock price of $39.46.